Production (Stage)
Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 518.30K | 516.10K | 481.10K | 483.80K | 546.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 518.30K | 516.10K | 481.10K | 483.80K | 546.40K |
| Cost of Revenue | 176.20K | 182.00K | 181.40K | 185.60K | 218.20K |
| Gross Profit | 342.10K | 334.10K | 299.60K | 298.10K | 328.00K |
| SG&A Expenses | 511.00K | 534.80K | 528.60K | 539.90K | 596.00K |
| Depreciation & Amortization | 90.90K | 79.00K | 78.70K | 79.40K | 79.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 778.00K | 795.70K | 788.60K | 804.80K | 893.80K |
| Operating Income | -259.90K | -279.80K | -307.60K | -321.00K | -347.40K |
| Income Before Tax | -323.50K | -334.70K | -356.20K | -359.70K | -393.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.32 | -0.33 | -0.36 | -0.36 | -0.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -323.50K | -334.70K | -356.20K | -359.70K | -393.60K |
| EBIT | -259.90K | -279.80K | -307.60K | -321.00K | -347.40K |
| EBITDA | -201.80K | -233.60K | -261.90K | -263.70K | -278.80K |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 275.54M | 275.54M | 275.54M | 275.54M | 275.54M |
| Average Diluted Shares Outstanding | 275.54M | 275.54M | 275.54M | 275.54M | 275.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |